4 Apr 2018
New liver cancer biomarker
Congratulations to SCAHT research group leader Prof. Luigi Terracciano and other collaborators of Prof. Michael N Hall at the University of Basel on their recent Nature publication (Hindupur et al 2018) describing the discovery of protein LHPP as a key tumor suppressor in mouse and human in vitro liver cancer cells.
In patients, low levels of LHPP were associated with increased tumour severity and reduced overall survival. LHPP could thus be used as a highly useful biomarker for diagnosis and prognosis of liver cancer.